Washington University in St Louis-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Washington University in St Louis - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013271
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Washington University in St Louis (Washington University), a subsidiary of University of Washington is an educational university that provides patient care and research services in the US. The university provides various courses of bachelor’s, master’s, and doctoral degrees in a wide range of traditional and interdisciplinary fields. It provides degree programs in the areas of law, engineering, education, business and international affairs, medicine, public health, and others. The university’s schools include School of Engineering & Applied Science, Sam Fox School of Design and Visual Arts, George Warren Brown School of Social Work, and others. Washington University is headquartered in St. Louis, Missouri, the US.

Washington University in St Louis – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Washington University in St Louis, Medical Devices Deals, 2011 to YTD 2017 9
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Washington University in St Louis, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Pfizer Enters into Agreement with Washington University in St. Louis 12
GenVec Enters into Agreement with Washington University in St. Louis 13
MaxCyte Enters into Agreement with Washington University in St Louis 14
Turing Pharma Enters into Partnership with Washington University 15
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 16
GenVec Enters into Agreement with Washington University at St. Louis 17
Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis 18
Licensing Agreements 19
ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 19
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 20
ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside 21
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 22
Washington University in St Louis – Key Competitors 23
Washington University in St Louis – Key Employees 24
Washington University in St Louis – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Government and Public Interest 26
Nov 02, 2017: Lung Cancer Research Foundation Awards $1.6 Million in Research Grants 26
Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 28
Sep 25, 2017: Human antibodies from dengue patients can effectively treat Zika infection in mice 29
Sep 25, 2017: Antibody protects against both Zika and dengue, mouse study shows 31
Mar 13, 2017: University Of Utah Engineers Use CRISPR Technology To Prevent Tissue Damage And Resulting Chronic Pain 33
Oct 04, 2016: Revolutionary Clinical Trial Initiative Focuses on Precision Medicine, Collaboration and Data Sharing to Transform Outcomes for All Pancreatic Cancer Patients 34
Sep 30, 2016: NHLBI Awards Grants to Help Improve Health Outcomes for Teens, Adults with Sickle Cell Disease 36
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 37
May 31, 2016: Researchers create first 3-D mathematical model of uterine contractions 39
Clinical Trials 40
Oct 26, 2017: NIH study identifies new targets for anti-malaria drugs 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Washington University in St Louis, Pharmaceuticals & Healthcare, Key Facts 2
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington University in St Louis, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington University in St Louis, Deals By Therapy Area, 2011 to YTD 2017 8
Washington University in St Louis, Medical Devices Deals, 2011 to YTD 2017 9
Washington University in St Louis, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pfizer Enters into Agreement with Washington University in St. Louis 12
GenVec Enters into Agreement with Washington University in St. Louis 13
MaxCyte Enters into Agreement with Washington University in St Louis 14
Turing Pharma Enters into Partnership with Washington University 15
Johnson & Johnson Innovation Enters into Research Agreement with Washington University 16
GenVec Enters into Agreement with Washington University at St. Louis 17
Cumberland Emerging Technologies Enters Into Agreement With Washington University in St. Louis 18
ViewPoint Therapeutics Receives Technology Rights from University of Michigan and Washington University 19
Sage Therapeutics Enters Into Licensing Agreement With Washington University To Develop Gaba Receptor Small Molecules 20
ChromaDex Enters Into Licensing Agreement With Washington University For Nicotinamide Riboside 21
Fimbrion Therapeutics Enters into Licensing Agreement with Washington University 22
Washington University in St Louis, Key Competitors 23
Washington University in St Louis, Key Employees 24
Washington University in St Louis, Subsidiaries 25

★海外企業調査レポート[Washington University in St Louis-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Thomson Reuters Corporation:企業の戦略・SWOT・財務分析
    Thomson Reuters Corporation - Strategy, SWOT and Corporate Finance Report Summary Thomson Reuters Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Merck & Co Inc (MRK)-医療機器分野:企業M&A・提携分析
    Summary Merck & Co Inc (Merck) focuses on the discovery, development, manufacture and commercialization of prescription pharmaceuticals, biologic therapies, vaccines and animal healthcare products. It offers prescription products for treating cardiovascular, cancer, immunology, infectious, respirato …
  • Thai Airways International Public Co Ltd:企業の戦略・SWOT・財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Analytik Jena AG:企業の戦略的SWOT分析
    Analytik Jena AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Newmont Mining Corp:企業の戦略・SWOT・財務情報
    Newmont Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Newmont Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mapletree Investments Pte Ltd:企業の戦略的SWOT分析
    Mapletree Investments Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Douglas Holding AG:戦略・SWOT・企業財務分析
    Douglas Holding AG - Strategy, SWOT and Corporate Finance Report Summary Douglas Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Translational Drug Development LLC-製薬・医療分野:企業M&A・提携分析
    Summary Translational Drug Development LLC (TD2) is a drug development organization offers oncology treatments to cancer patients. The organization offers services which include regulatory affairs services, preclinical services, clinical services, and others. It also offers in vivo services, isogeni …
  • Enzymatica AB (ENZY):製薬・医療:M&Aディール及び事業提携情報
    Summary Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and de …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Eli Lilly and Co (LLY)-医療機器分野:企業M&A・提携分析
    Summary Eli Lilly and Company (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, critical care, men's health and musculoskeletal problems. It a …
  • Kuoni Travel Holding Ltd.:企業の戦略・SWOT・財務情報
    Kuoni Travel Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuoni Travel Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Middle East Airlines:企業の戦略・SWOT・財務情報
    Middle East Airlines - Strategy, SWOT and Corporate Finance Report Summary Middle East Airlines - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Surgical Innovations Group Plc (SUN):医療機器:M&Aディール及び事業提携情報
    Summary Surgical Innovations Group plc (Surgical Innovations) designs, develops, manufactures and markets medical devices for use in minimally invasive surgery (MIS) and industrial markets. The company offers SI branded products and products for selected original equipment manufacturer (OEM) partner …
  • InSphero AG:製薬・医療:M&Aディール及び事業提携情報
    Summary InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture p …
  • Fisher & Paykel Appliances Holdings Limited:企業の戦略的SWOT分析
    Fisher & Paykel Appliances Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • NIIT Technologies Ltd (NIITTECH):企業の財務・戦略的SWOT分析
    Summary NIIT Technologies Ltd (NIIT Technologies) is a technology company that provides information technology solutions. The company provides software products such as AdvantageSuite, an insurance technology solution based on Microsoft Azure cloud platform. It offers services such as application ma …
  • JA Solar Holdings Co Ltd (JASO):企業の財務・戦略的SWOT分析
    JA Solar Holdings Co Ltd (JASO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Isuzu Motors Limited:企業の戦略・SWOT・財務情報
    Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Isuzu Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • First Solar Inc (FSLR):企業の財務・戦略的SWOT分析
    First Solar Inc (FSLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆